Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Varegacestat · AL102, BMS-986115

Small molecule · Inhibitor of gamma secretase complex and Notch receptor (NOTCH1) · developed by Immunome

Phase 2/3 Most advanced trial
IMNM Developer
3 Registered trials

What is Varegacestat?

Varegacestat is an orally bioavailable gamma secretase and pan-Notch inhibitor. It binds gamma secretase and blocks cleavage and release of the Notch intracellular domain, preventing Notch-regulated gene expression. It is being studied in desmoid tumors.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
AL102, BMS-986115
Drug type
Small molecule
Targets
gamma secretase complex, Notch receptor (NOTCH1)
Mechanism
Inhibitor of gamma secretase complex and Notch receptor (NOTCH1)
Pathways
Notch signaling, apoptosis
Therapy area
Oncology
Developer
Immunome, Inc. (IMNM)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2/3
UNII
LSK1L593UU

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT04871282 Phase 2/3 Desmoid Active not recruiting IMNM
NCT07610005 Phase 1 Healthy Recruiting IMNM
NCT06841315 Phase 1 Healthy Volunteer Completed IMNM

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

DesmoidDesmoid TumorHealthyHealthy VolunteerHepatic Impairment (HI)

More from Immunome

Sources

Updated Oct 18, 2026. Something wrong or missing? Report it on the IMNM page.

Follow IMNM, the company behind Varegacestat

See IMNM's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

IMNM catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.